A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants
Clinical trial NCT06193031 · COMPLETED
Trial details
- NCT number
- NCT06193031
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-17
- Primary completion
- 2015-12-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.